(Lond.) 4:137
Saying 'I'm taking peptides' is a bit like saying 'I'm taking medication.' It's important to know which one, what it's for, and what the evidence is saying
In the remaining 3 studies [107,109,111], there was no statistically significant association between tea drinking and PTB, but lower tea intake was reported in these studies
The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible
Also on the horizon is the possibility of an oral GLP-1 mimic that could be paired with pioglitazone or with their newly formulated thiazolidinedione drug
Our clinicians monitor response closely and make timely adjustments to improve effectiveness
